Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

All-new Line of Regulated AC-DC Converters

September 12, 2013 3:12 pm | by MDT Staff | Product Releases | Comments

UltraVolt has announced the launch of its newest line of single output high-voltage modules – the B Series. The new line of “Basic” performance AC-DC high-voltage modules, the B Series, consists of 12 models that provide fixed outputs of 1kV to 12kV at 4, 20, 30, or 50 watts of output power. B Series units are available with an input voltage of either 115VAC or 230VAC.

Appeals court reverses St. Jude Medical win over Access Closure

September 12, 2013 2:10 pm | by Mass Device | News | Comments

A federal appeals court overturned a portion of a legal win for St. Jude Medical yesterday, ruling that a lower court erred in invoking the "safe harbor" provision against double-patenting claims in a patent infringement lawsuit against Access Closure Inc.

TOPICS:

Appeals court upholds Medtronic win over Gore in stent graft suit

September 12, 2013 1:42 pm | by Mass Device | News | Comments

A federal appeals court upheld a lower court's decision to toss a lawsuit filed in 2010 accusing Medtronic of violating patents held by W.L. Gore & Associates covering stent graft manufacturing techniques. Judge Mark Davis of the U.S. District Court for Eastern Virginia dismissed Gore's claims last year, saying the ruling made Medtronic's counterclaims moot.

TOPICS:
Advertisement

II-VI Buys Oclaro's Semiconductor Laser Business

September 12, 2013 1:32 pm | by The Associated Press | News | Comments

Laser and optics manufacturer II-VI Inc. has acquired the semiconductor laser business of Oclaro Inc. for $92 million. As part of the deal, Oclaro retained $15 million in accounts receivable. In addition, $6 million of cash is being held back by II-VI for 15 months and another $2 million is being held back by II-VI for...

Virginia Tech Carilion Researchers Find Surprising Relationships in Brain Signaling

September 12, 2013 11:48 am | by Paula Byron, Virginia Tech | News | Comments

If the violins were taken away from the musicians performing Beethoven's 9th symphony, the resulting composition would sound very different. If the violins were left on stage but the violinists were removed, the same mutant version of the symphony would be heard. But what if it ended up sounding like "Hey Jude" instead?

TOPICS:

Catching the Silent Thief of Sight

September 12, 2013 11:04 am | by A-Star Research | News | Comments

A team of researchers led by Jun Cheng of the A*STAR Institute for Infocomm Research, Singapore, has developed a novel automated technology that screens for glaucoma more accurately and quickly than existing methods.      

TOPICS:

Spatial Reach for Infection and Cancer Detection

September 12, 2013 10:59 am | by Team Consulting | Videos | Comments

Team Consulting (a UK-based medical product development consultancy) has unveiled an innovative concept that has the potential to address two significant unmet clinical needs; early detection of cancer regrowth following surgery and detection of infection within chronic wounds.

TOPICS:

Titan Medical Completes Functional Prototype of SPORT Surgical System

September 12, 2013 10:52 am | by Titan Medical | News | Comments

Titan Medical Inc. has announced that it has successfully completed development of a functional prototype of its Single Port Orifice Robotic Technology (SPORT™) Surgical System. The SPORT™ Surgical System prototype successfully demonstrates the key features of the system, including...

TOPICS:
Advertisement

How Technology Allowed Me to Read

September 12, 2013 10:46 am | by TED | Videos | Comments

Months after he was born, in 1948, Ron McCallum became blind. In this charming, moving talk, he shows how he is able to read – and celebrates the progression of clever tools and adaptive computer technologies that make it possible. With their help, and that of generous volunteers...

TOPICS:

The Pulse: Robots Remove Brain Tumors

September 12, 2013 10:12 am | by Eric Sorensen, Coordinator of Multimedia Development | Videos | Comments

On this episode of The Pulse, brought to you by MDT TV, we’re removing brain tumors with robots, using MetaboShield to help obesity, regenerating heart tissue, and pairing glucometers with smartphones for ease of use.      

TOPICS:

FDA Approval for Endovascular Repair of Aortic Dissection

September 12, 2013 10:12 am | by W. L. Gore & Associates | News | Comments

W. L. Gore & Associates (Gore) has announced that the US Food and Drug Administration (FDA) has approved the Conformable GORE® TAG® Thoracic Endoprosthesis for endovascular repair of acute and chronic Type B dissections of the descending thoracic aorta. This durable endoprosthesis is the only device to...

TOPICS:

"Incidental Findings" Rare But Significant Events in Pediatric CT Scans

September 12, 2013 10:03 am | by UC Davis | News | Comments

The largest study of computed tomographic (CT) scans taken in emergency departments across the country for children with head injuries describes the prevalence of “incidental findings” and categorizes them by urgency. The study involved nearly 44,000 children seen for a head injury in 25 hospital emergency departments nationwide. Nearly 16,000 had CT scans to evaluate an injury, and about 4 percent of the scans revealed...

TOPICS:

Researchers Hit Virtual Heads to Make Safer Games

September 12, 2013 9:56 am | by Lloyd Smith, Washington State University | News | Comments

In many sports, balls are standardized for consistency and performance. But, researchers haven't understood specifically how the balls' different properties and materials affect player safety. They haven't been able to measure just how much or how it hurts when a ball hits a head.

TOPICS:

Nanodiamonds to Deliver Chemotherapy Drugs Directly to Brain Tumors

September 12, 2013 9:54 am | by Shaun Mason, University of California - Los Angeles | News | Comments

The researchers found that ND–DOX levels in the tumors were retained for a duration far beyond that of doxorubicin alone, showing that doxorubicin was taken into the tumor and remained their longer when attached to nanodiamonds. In addition, ND–DOX was also found to increase...

TOPICS:

Arch Biopartners Announces Issuance of U.S. Patent for Brain Tumor Cell Targeting Technology

September 12, 2013 9:09 am | by The Associated Press | News | Comments

Arch Biopartners Inc announced today that the U.S. Patent and Trademark Office has issued US Patent 8,530,429 protecting its peptide technology which targets brain tumour initiating cells (BTICs) and invasive glioma cells (IGCs). The patent protects novel synthetic peptides that target and attach to human BTICs and IGCs.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading